We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-6.93%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1,000M
AUM Growth
+$239M
Cap. Flow
+$349M
Cap. Flow %
34.94%
Top 10 Hldgs %
8.93%
Holding
1,387
New
562
Increased
225
Reduced
140
Closed
460

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$12M
2
VZ icon
Verizon
VZ
+$11.7M
3
CMCSA icon
Comcast
CMCSA
+$10.3M
4
PG icon
Procter & Gamble
PG
+$7.96M
5
LBRDK icon
Liberty Broadband Class C
LBRDK
+$6.85M

Top Sells

Rank Stock Value
1
MPC icon
Marathon Petroleum
MPC
+$8.93M
2
AMGN icon
Amgen
AMGN
+$5.81M
3
COP icon
ConocoPhillips
COP
+$5.66M
4
ILMN icon
Illumina
ILMN
+$5.4M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 16.44%
2 Consumer Discretionary 11.9%
3 Financials 11.76%
4 Industrials 10.6%
5 Healthcare 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AWH
1351
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
-1,898
Closed -$17K
PXD
1352
DELISTED
Pioneer Natural Resource Co.
PXD
-5,662
Closed -$1.26M
KAMN
1353
DELISTED
Kaman Corp
KAMN
-6,694
Closed -$209K
CBAY
1354
DELISTED
Cymabay Therapeutics
CBAY
-23,644
Closed -$70K
LTRPA
1355
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
-12,277
Closed -$9K
NATI
1356
DELISTED
National Instruments Corp
NATI
-18,449
Closed -$576K
PRTK
1357
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
-18,613
Closed -$36K
INFI
1358
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-41,396
Closed -$26K
FXLV
1359
DELISTED
F45 Training Holdings Inc.
FXLV
-27,123
Closed -$107K
IDEX
1360
DELISTED
Ideanomics, Inc. Common Stock
IDEX
-635
Closed -$53K
MTEM
1361
DELISTED
Molecular Templates, Inc.
MTEM
-915
Closed -$13K
PDCE
1362
DELISTED
PDC Energy, Inc.
PDCE
-15,047
Closed -$927K
SPPI
1363
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
-26,513
Closed -$21K
NMTR
1364
DELISTED
9 Meters Biopharma
NMTR
-9,216
Closed -$48K
XM
1365
DELISTED
Qualtrics International Inc. Class A Common Stock
XM
-58,555
Closed -$733K
MYOV
1366
DELISTED
Myovant Sciences Ltd.
MYOV
-11,198
Closed -$139K
COUP
1367
DELISTED
Coupa Software Incorporated
COUP
-8,225
Closed -$470K
ATNX
1368
DELISTED
Athenex, Inc. Common Stock
ATNX
-777
Closed -$6K
CIXX
1369
DELISTED
CI Financial Corp.
CIXX
-56,668
Closed -$602K
DS
1370
DELISTED
Drive Shack Inc.
DS
-12,837
Closed -$18K
CLVS
1371
DELISTED
Clovis Oncology, Inc.
CLVS
-11,630
Closed -$21K
QTNT
1372
DELISTED
Quotient Limited Ordinary Shares
QTNT
-439
Closed -$4K
RMO
1373
DELISTED
Romeo Power, Inc.
RMO
-14,683
Closed -$7K
TMX
1374
DELISTED
Terminix Global Holdings, Inc.
TMX
-7,331
Closed -$298K
AMPE
1375
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-92
Closed -$5K

Similar funds

Y-Intercept (HK)'s Q3 2022 Portfolio in Review

As of Q3 2022, Y-Intercept (HK) held 1,387 positions worth $1,000M, up 31% from $761M the previous quarter. Its ten largest holdings account for 8.9% of the portfolio.

Y-Intercept (HK) deployed $349M of net new capital in Q3 2022, opening 562 new positions and adding to 225 existing holdings. Its largest new stake was Chevron: 78,786 shares worth $11.3M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Marathon Petroleum, an estimated $8.93M trimmed.

  • Y-Intercept (HK)'s largest Q3 2022 buy was Chevron: 78,786 shares worth $11.3M.
  • Y-Intercept (HK) added most to Comcast in Q3 2022, an estimated $10.3M increase.
  • Y-Intercept (HK)'s biggest Q3 2022 reduction was Marathon Petroleum, cutting an estimated $8.93M.
  • Y-Intercept (HK) fully exited Amgen in Q3 2022, selling an estimated $5.81M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.9% of its $1,000M portfolio in Q3 2022.
  • Y-Intercept (HK) opened 562 new positions and closed 460 in Q3 2022.
  • Y-Intercept (HK)'s portfolio value rose 31% quarter-over-quarter to $1,000M.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.